Today’s Hottest: Abaxis (NASDAQ:ABAX), Ares Management, L.P. (NYSE:ARES), Allegiance Bancshares (NASDAQ:ABTX), Eyegate Pharmaceuticals (NASDAQ:EYEG)

Old Republic International Corporation (NYSE:ORI) shares moved up 0.44% in last trading session and ended the day at $18.44. ORI has a return on assets of 2.40%. Old Republic International Corporation (NYSE:ORI) quarterly performance is 2.61%.

Old Republic International Corporation (NYSE:ORI) announced that it will hold a conference call on Thursday, April 28, at 3:00 p.m. Eastern Time to discuss first quarter 2016 results.

Abaxis, Inc. (NASDAQ:ABAX) ended the last trading day at $45.96. Company weekly volatility is calculated as 3.11% and price to cash ratio as 7.69. Abaxis, Inc. (NASDAQ:ABAX) showed a weekly performance of 1.12%.

On 26 April, Ares Management, L.P. (NYSE:ARES) shares moved up 1.37% and was closed at $15.54. ARES EPS growth in last 5 year was -40.50%. Ares Management, L.P. (NYSE:ARES) year to date (YTD) performance is 22.06%.

Ares Management, L.P. (NYSE:ARES) announced that it will report earnings for the first quarter ended March 31, 2016 on Tuesday, May 10, 2016 prior to the opening of the New York Stock Exchange. Ares Management, L.P. invites all interested persons to attend its webcast/conference call on the same day at 12:00 p.m. (Eastern Time) to discuss its first quarter 2016 financial results.

Allegiance Bancshares, Inc. (NASDAQ:ABTX) shares moved up 6.89% in last trading session and ended the day at $21.40. ABTX has a return on assets of 0.80%. Allegiance Bancshares, Inc. (NASDAQ:ABTX) quarterly performance is 24.85%.

Allegiance Bancshares, Inc. (NASDAQ:ABTX), reported net income attributable to common stockholders of $6.4 million in the first quarter 2016, a 90.0% increase over the prior year period and a 50.9% increase compared to the fourth quarter 2015. Net income per diluted common share increased 48.5% to $0.49 compared to net income per diluted common share of $0.33 for both the first quarter 2015 and the fourth quarter 2015.

Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) caters to the Healthcare space. Its weekly performance is 2.43%. On the last day of trading company shares ended up at $3.37.

Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) announced that four abstracts supporting the ongoing development of its proprietary technology cross-linked hyaluronic acid polymer (CMHA-S) have been accepted for poster presentation at the upcoming 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) being held May 1-5, 2016 in Seattle, WA.